188 related articles for article (PubMed ID: 2908581)
1. Leukocyte subsets in the granulomatous response produced after inoculation with Mycobacterium leprae-BCG in lepromatous patients.
Gross A; Weiss E; Tapia FJ; Aranzazu N; Gallinoto ME; Convit J
Am J Trop Med Hyg; 1988 May; 38(3):608-12. PubMed ID: 2908581
[TBL] [Abstract][Full Text] [Related]
2. Analysis of cytokine production by Mycobacterium-reactive T cells. Failure to explain Mycobacterium leprae-specific nonresponsiveness of peripheral blood T cells from lepromatous leprosy patients.
Mutis T; Kraakman EM; Cornelisse YE; Haanen JB; Spits H; De Vries RR; Ottenhoff TH
J Immunol; 1993 May; 150(10):4641-51. PubMed ID: 8482851
[TBL] [Abstract][Full Text] [Related]
3. Restoration of proliferative response to M. leprae antigens in lepromatous T cells against candidate antileprosy vaccines.
Mustafa AS
Int J Lepr Other Mycobact Dis; 1996 Sep; 64(3):257-67. PubMed ID: 8862259
[TBL] [Abstract][Full Text] [Related]
4. T cell response to purified filtrate antigen 85 from Mycobacterium bovis Bacilli Calmette-Guérin (BCG) in leprosy patients.
Launois P; Huygen K; De Bruyn J; N'Diaye M; Diouf B; Sarthouj L; Grimaud J; Millan J
Clin Exp Immunol; 1991 Nov; 86(2):286-90. PubMed ID: 1934596
[TBL] [Abstract][Full Text] [Related]
5. Experimental Mycobacterium leprae infection in BALB/c mice: effect of BCG administration on TNF-alpha production and granuloma development.
Aarestrup FM; Sampaio EP; de Moraes MO; Albuquerque EC; Castro AP; Sarno EN
Int J Lepr Other Mycobact Dis; 2000 Jun; 68(2):156-66. PubMed ID: 11036496
[TBL] [Abstract][Full Text] [Related]
6. In situ demonstration of T lymphocyte subsets in granulomatous inflammation: leprosy, rhinoscleroma and sarcoidosis.
Modlin RL; Hofman FM; Meyer PR; Sharma OP; Taylor CR; Rea TH
Clin Exp Immunol; 1983 Mar; 51(3):430-8. PubMed ID: 6221839
[TBL] [Abstract][Full Text] [Related]
7. HLA-DQ molecules and the control of Mycobacterium leprae-specific T cell nonresponsiveness in lepromatous leprosy patients.
Ottenhoff TH; Walford C; Nishimura Y; Reddy NB; Sasazuki T
Eur J Immunol; 1990 Oct; 20(10):2347-50. PubMed ID: 1700754
[TBL] [Abstract][Full Text] [Related]
8. T cell responses to fractionated Mycobacterium leprae antigens in leprosy. The lepromatous nonresponder defect can be overcome in vitro by stimulation with fractionated M. leprae components.
Ottenhoff TH; Converse PJ; Gebre N; Wondimu A; Ehrenberg JP; Kiessling R
Eur J Immunol; 1989 Apr; 19(4):707-13. PubMed ID: 2659369
[TBL] [Abstract][Full Text] [Related]
9. Cloned suppressor T cells from a lepromatous leprosy patient suppress Mycobacterium leprae reactive helper T cells.
Ottenhoff TH; Elferink DG; Klatser PR; de Vries RR
Nature; 1986 Jul 31-Aug 6; 322(6078):462-4. PubMed ID: 2426597
[TBL] [Abstract][Full Text] [Related]
10. Reduced suppressor cell response to Mycobacterium leprae in lepromatous leprosy.
Sasiain MD; de la Barrera S; Valdez R; Balina LM
Infect Immun; 1989 Mar; 57(3):951-6. PubMed ID: 2521841
[TBL] [Abstract][Full Text] [Related]
11. The mycobacterial secreted antigen 85 complex possesses epitopes that are differentially expressed in human leprosy lesions and Mycobacterium leprae-infected armadillo tissues.
Rambukkana A; Burggraaf JD; Faber WR; Harboe M; Teeling P; Krieg S; Das PK
Infect Immun; 1993 May; 61(5):1835-45. PubMed ID: 7682995
[TBL] [Abstract][Full Text] [Related]
12. The role of interleukin-2 (IL-2) in the specific unresponsiveness of lepromatous leprosy to Mycobacterium leprae: studies in vitro and in vivo.
Haregewoin A; Longley J; Bjune G; Mustafa AS; Godal T
Immunol Lett; 1985; 11(3-4):249-52. PubMed ID: 3936783
[TBL] [Abstract][Full Text] [Related]
13. In situ demonstration of Mycobacterium leprae antigens in leprosy lesions using monoclonal antibodies.
Narayanan RB; Girdhar BK; Malaviya GN; Sengupta U
Immunol Lett; 1990 Jun; 24(3):179-83. PubMed ID: 2200752
[TBL] [Abstract][Full Text] [Related]
14. Cellular and humoral immune responses to recombinant 65-kD antigen of Mycobacterium leprae in leprosy patients and healthy controls.
Ilangumaran S; Shanker Narayan NP; Ramu G; Muthukkaruppan VR
Clin Exp Immunol; 1994 Apr; 96(1):79-85. PubMed ID: 8149671
[TBL] [Abstract][Full Text] [Related]
15. Restoration of defective cytokine activity within lepromatous leprosy lesions.
Volc-Platzer B; Kremsner P; Stemberger H; Wiedermann G
Zentralbl Bakteriol; 1990 Apr; 272(4):458-66. PubMed ID: 1972881
[TBL] [Abstract][Full Text] [Related]
16. On the mechanism of human T cell suppression.
Salgame P; Modlin R; Bloom BR
Int Immunol; 1989; 1(2):121-9. PubMed ID: 2535060
[TBL] [Abstract][Full Text] [Related]
17. Mycobacterium leprae reactive T cell clones from lepromatous leprosy patients after prolonged dapsone chemotherapy.
Gill HK; Ridley DS; Ganesan J; Mustafa AS; Rees RJ; Godal T
Lepr Rev; 1990 Mar; 61(1):25-31. PubMed ID: 2181222
[TBL] [Abstract][Full Text] [Related]
18. A follow up of T-cell subsets and of anti-M. leprae antibody titer as measured by the FLA-ABS test in Melanesian leprosy patients under polychemotherapy.
Garraud O; Ribierre O; Bach MA
Int J Lepr Other Mycobact Dis; 1986 Mar; 54(1):38-45. PubMed ID: 2940306
[TBL] [Abstract][Full Text] [Related]
19. Alteration of T cell subset pattern among in vitro M. leprae-stimulated blood lymphocytes of leprosy patients.
Corbeau P; Desforges S; Bach MA
Acta Leprol; 1989; 7 Suppl 1():171-2. PubMed ID: 2569800
[No Abstract] [Full Text] [Related]
20. M. leprae- and BCG-induced chemiluminescence response of monocytes from leprosy patients and healthy subjects: effects of gamma-interferon and GM-CSF.
Launois P; Blum L; Dieye A; Millan J; Sarthou JL; Michel JC; Bach MA
Int J Lepr Other Mycobact Dis; 1991 Dec; 59(4):582-9. PubMed ID: 1802941
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
